The pharmacologic treatment of anxiety disorders: a review of progress.
about
Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adultsBiological predictors of pharmacological therapy in anxiety disordersPsychiatric Disorders and TRP Channels: Focus on Psychotropic DrugsTreatment-refractory anxiety; definition, risk factors, and treatment challengesPharmacological treatment of anxiety disorders: current treatments and future directionsCombined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches.Dynorphin Controls the Gain of an Amygdalar Anxiety CircuitNeuroimaging in anxiety disorders.Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environmentsLoop diuretics have anxiolytic effects in rat models of conditioned anxietyThe efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating ScalesThe clinical implications of mouse models of enhanced anxiety.Methylphenidate and desipramine combined treatment improves PTSD symptomatology in a rat modelThe crossroads of anxiety: distinct neurophysiological maps for different symptomatic groupsDifferential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD studyOptimizing fitness for duty and post-combat clinical services for military personnel and combat veterans with ADHD-a systematic review of the current literature.Disseminating treatment for anxiety disorders step 2: peer recommendations to seek help.Pharmacological treatment for generalized anxiety disorder in adults: an update.Citrus aurantium L. essential oil exhibits anxiolytic-like activity mediated by 5-HT(1A)-receptors and reduces cholesterol after repeated oral treatment.Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary careCellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice.MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders.Treatment of substance abusing patients with comorbid psychiatric disorders.A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors.Publication trends in newspapers and scientific journals for SSRIs and suicidality: a systematic longitudinal study.Ceruloplasmin deficiency results in an anxiety phenotype involving deficits in hippocampal iron, serotonin, and BDNF.Pharmacotherapy of anxiety disorders: a critical reviewComparison of treatment adherence between selective serotonin reuptake inhibitors and moclobemide in patients with social anxiety disorderPregabalin effects on neural response to emotional faces.Neurosteroids as neuromodulators in the treatment of anxiety disorders.Optimal treatment of social phobia: systematic review and meta-analysis.Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression.Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder.The role of the dynorphin/κ opioid receptor system in anxiety.mGluR₁,5 activation improves network asynchrony and GABAergic synapse attenuation in the amygdala: implication for anxiety-like behavior in DBA/2 mice.Riluzole effect on occipital cortex: a structural and spectroscopy pilot study.Electrophysiological Assessment of Serotonin and GABA Neuron Function in the Dorsal Raphe during the Third Trimester Equivalent Developmental Period in Mice.Toxoplasma gondii infection induces dendritic retraction in basolateral amygdala accompanied by reduced corticosterone secretion.Current diagnosis and treatment of anxiety disorders.Temporal association of elevated cholecystokininergic tone and adolescent trauma is critical for posttraumatic stress disorder-like behavior in adult mice.
P2860
Q24195085-7AC121FC-5CFE-40AB-BCF0-22BDAFD5AC47Q26781100-3CC26F0C-C148-4094-89D1-FF920F2EE484Q26786474-58AB4C80-A23B-4173-A3FF-8CF317649CF8Q26798229-A9BA700F-38CD-426D-BAC8-64B2380E6115Q26851461-BAB957EB-68F4-49EC-AF1A-4B8826995F1FQ27300710-1D2D305C-D9AE-4824-9EEE-CDBE0E25463CQ27319741-BC1C5D28-117B-409A-B1C6-1B1B85CC3A4DQ27686845-602AB379-2EE3-4A8E-B61A-48172DB03ECFQ28384182-83BA72F9-FAFE-4D35-8747-35E8D25AD37FQ28482301-49E66621-D954-40F6-A301-37E59C779B76Q28542596-AE207DAD-7A53-4126-B84B-79E4EE4EC9E2Q30474232-4E4ADECC-31AE-499F-B209-BDF45246A944Q30594365-C5D1E68F-CE3D-4A7A-B26F-2EF3AAB206DBQ33362466-364B35A4-9931-48E3-9B54-E5A05D10C6CBQ33835886-76AFECE8-FDF6-4683-9FDC-500F17199184Q34068767-E9974DEE-62BE-4444-A88D-4E61F4EC2D03Q34160773-4C523750-C953-4E83-8AD8-14AC0BC6AC12Q34484276-BBBBCA6E-BB41-4D56-A5E6-3B12A54279CFQ34596067-CF737F18-E44F-4708-9E71-78014BEE02C9Q34779556-620971AB-9473-4AB9-B250-6E62BB8D5FC3Q35032878-9794C1C9-0D8F-4D3E-A9C5-9DFA7565FDEEQ35151007-8D0470F3-4C07-4791-BAEC-C3BA6ED553F9Q35387756-9ABAB0C9-77F9-4811-B7CE-9EF68D889137Q35545279-E4499943-D76E-4974-805D-584DB3A37DE0Q35610240-C8406073-8479-49B1-988F-485B89EE9AFBQ35618999-705C830A-BAC4-462C-867A-4AF669AD72B6Q35686859-CE231925-EDA5-4580-8248-86F821EF73ABQ35775549-212D0DC1-150D-4243-80BA-ED879391D62FQ35855502-EC9D1E61-D421-4449-8014-E006ABCAFDFBQ35971707-30E9CAEE-89FD-4719-AFD2-2495D345FCC9Q35997293-60D72394-93AE-43E2-AFC3-61F192ED00E1Q36082786-1B96B188-CC97-48D3-A2F6-F2DFBFF869CFQ36174067-40399541-92E4-461C-988E-D9D3E4A71D6CQ36287728-F25B1464-206C-4BDD-BEF3-977288D707FDQ36329100-9AD0A76C-E43D-49A1-93D3-7774CD327F46Q36374329-FF22D9AF-3343-4A5B-BCE4-371DFCE3B2BAQ36422914-B6141592-7D89-4EFB-9184-98E0A3C55920Q36683107-3F1F6A32-4AE9-4A91-BCD7-956DF25B7AC3Q36771550-2CC255EB-C75A-4E97-B908-CA4DB85C2C85Q36782164-458B3CD3-5FB5-4D88-BBA1-1A6B754BB9C0
P2860
The pharmacologic treatment of anxiety disorders: a review of progress.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The pharmacologic treatment of anxiety disorders: a review of progress.
@ast
The pharmacologic treatment of anxiety disorders: a review of progress.
@en
The pharmacologic treatment of anxiety disorders: a review of progress.
@nl
type
label
The pharmacologic treatment of anxiety disorders: a review of progress.
@ast
The pharmacologic treatment of anxiety disorders: a review of progress.
@en
The pharmacologic treatment of anxiety disorders: a review of progress.
@nl
prefLabel
The pharmacologic treatment of anxiety disorders: a review of progress.
@ast
The pharmacologic treatment of anxiety disorders: a review of progress.
@en
The pharmacologic treatment of anxiety disorders: a review of progress.
@nl
P356
P1476
The pharmacologic treatment of anxiety disorders: a review of progress.
@en
P2093
Lakshmi N Ravindran
Murray B Stein
P304
P356
10.4088/JCP.10R06218BLU
P577
2010-07-01T00:00:00Z